chr1-86560334-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_012128.4(CLCA4):āc.424A>Cā(p.Lys142Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,613,822 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012128.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCA4 | NM_012128.4 | c.424A>C | p.Lys142Gln | missense_variant | 3/14 | ENST00000370563.3 | NP_036260.2 | |
CLCA4 | XM_011541015.3 | c.271A>C | p.Lys91Gln | missense_variant | 3/14 | XP_011539317.1 | ||
CLCA4 | NR_024602.2 | n.466A>C | non_coding_transcript_exon_variant | 3/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCA4 | ENST00000370563.3 | c.424A>C | p.Lys142Gln | missense_variant | 3/14 | 1 | NM_012128.4 | ENSP00000359594 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000325 AC: 81AN: 248912Hom.: 1 AF XY: 0.000385 AC XY: 52AN XY: 135060
GnomAD4 exome AF: 0.000228 AC: 333AN: 1461502Hom.: 2 Cov.: 31 AF XY: 0.000264 AC XY: 192AN XY: 727078
GnomAD4 genome AF: 0.000171 AC: 26AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.424A>C (p.K142Q) alteration is located in exon 3 (coding exon 3) of the CLCA4 gene. This alteration results from a A to C substitution at nucleotide position 424, causing the lysine (K) at amino acid position 142 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at